Barbara Klencke - Apr 6, 2023 Form 3 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Barbara Klencke
Stock symbol
TCRX
Transactions as of
Apr 6, 2023
Transactions value $
$0
Form type
3
Date filed
4/10/2023, 10:35 AM
Previous filing
Jan 24, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TCRX Voting Common Stock 25K Apr 6, 2023 Direct
holding TCRX Voting Common Stock 25K Apr 6, 2023 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Klencke Huestis Trust, for which the Reporting Person serves as co-trustee along with her spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.